Zollinger-Ellison syndrome medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 18: | Line 18: | ||
:*[[5-fluorouracil]] | :*[[5-fluorouracil]] | ||
:*[[Doxorubicin]] | :*[[Doxorubicin]] | ||
*Hormonal therapy | *[[Hormonal therapy]] | ||
:*[[Octreotide]] can be used to slow down acid secretion | :*[[Octreotide]] can be used to slow down acid secretion | ||
Revision as of 18:42, 2 October 2015
Zollinger-Ellison syndrome Microchapters |
Differentiating Zollinger-Ellison syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Zollinger-Ellison syndrome medical therapy On the Web |
American Roentgen Ray Society Images of Zollinger-Ellison syndrome medical therapy |
Risk calculators and risk factors for Zollinger-Ellison syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Pharmacologic medical therapies for Zollinger-Ellison syndrome include proton pump inhibitors, H2-receptor antagonists, Chemotherapy, and hormonal therapy.
Medical Therapy
Medical therapy for Zollinger-Ellison syndrome may includes the following:[1]
- Used for tumors that can not be surgically resected
- Streptozotocin
- 5-fluorouracil
- Doxorubicin
- Octreotide can be used to slow down acid secretion
References
- ↑ Zollinger-Ellison syndrome 2015.https://en.wikipedia.org/wiki/Zollinger%E2%80%93Ellison_syndrome